Carl N. Kraus - 09 Aug 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role: Chief Medical Officer
Signature: /s/ Lori Braender, as Attorney-In-Fact
Issuer symbol: AQST
Transactions as of: 09 Aug 2025
Net transactions value: -$42,194
Form type: 4
Filing time: 12 Aug 2025, 10:11:01 UTC
Previous filing: 11 Mar 2025
Next filing: 17 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kraus Carl N	Chief Medical Officer	C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN	/s/ Lori Braender, as Attorney-In-Fact	12 Aug 2025	0001946475

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AQST	Common Stock	Tax liability	$42,194	-10,819	-3.5%	$3.90	302,747	09 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.